Medical device biocompatibility evaluation involves two distinct but complementary approaches: chemical characterization and biological testing. Understanding when each is required—and how they work together—is essential for efficient regulatory submissions and comprehensive safety evaluation. Many manufacturers struggle with determining the appropriate balance between these approaches. Over-reliance on biological testing can miss critical chemical safety concerns, while foc